578 related articles for article (PubMed ID: 28263995)
21. From Antihistamine to Anti-infective: Loratadine Inhibition of Regulatory PASTA Kinases in Staphylococci Reduces Biofilm Formation and Potentiates β-Lactam Antibiotics and Vancomycin in Resistant Strains of
Cutrona N; Gillard K; Ulrich R; Seemann M; Miller HB; Blackledge MS
ACS Infect Dis; 2019 Aug; 5(8):1397-1410. PubMed ID: 31132246
[No Abstract] [Full Text] [Related]
22. Effect of proteases against biofilms of Staphylococcus aureus and Staphylococcus epidermidis.
Elchinger PH; Delattre C; Faure S; Roy O; Badel S; Bernardi T; Taillefumier C; Michaud P
Lett Appl Microbiol; 2014 Nov; 59(5):507-13. PubMed ID: 25041576
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus and Staphylococcus epidermidis infections on implants.
Oliveira WF; Silva PMS; Silva RCS; Silva GMM; Machado G; Coelho LCBB; Correia MTS
J Hosp Infect; 2018 Feb; 98(2):111-117. PubMed ID: 29175074
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.
Kaplan JB; LoVetri K; Cardona ST; Madhyastha S; Sadovskaya I; Jabbouri S; Izano EA
J Antibiot (Tokyo); 2012 Feb; 65(2):73-7. PubMed ID: 22167157
[TBL] [Abstract][Full Text] [Related]
25. Strong biofilm production but not adhesion virulence factors can discriminate between invasive and commensal Staphylococcus epidermidis strains.
Mekni MA; Bouchami O; Achour W; Ben Hassen A
APMIS; 2012 Aug; 120(8):605-11. PubMed ID: 22779682
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162.
Kong C; Chee CF; Richter K; Thomas N; Abd Rahman N; Nathan S
Sci Rep; 2018 Feb; 8(1):2758. PubMed ID: 29426873
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
[TBL] [Abstract][Full Text] [Related]
28. Effect of incubation atmosphere on the production and composition of staphylococcal biofilms.
Asai K; Yamada K; Yagi T; Baba H; Kawamura I; Ohta M
J Infect Chemother; 2015 Jan; 21(1):55-61. PubMed ID: 25454214
[TBL] [Abstract][Full Text] [Related]
29. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
[TBL] [Abstract][Full Text] [Related]
30. Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics.
Gomes F; Teixeira P; Cerca N; Ceri H; Oliveira R
Microb Drug Resist; 2011 Jun; 17(2):191-6. PubMed ID: 21395450
[TBL] [Abstract][Full Text] [Related]
31. Enhanced activity of carvacrol against biofilm of Staphylococcus aureus and Staphylococcus epidermidis in an acidic environment.
Nostro A; Cellini L; Zimbalatti V; Blanco AR; Marino A; Pizzimenti F; Di Giulio M; Bisignano G
APMIS; 2012 Dec; 120(12):967-73. PubMed ID: 23030501
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of polysaccharide intercellular adhesion (PIA) and glycerol teichoic acid (Gly-TA) arisen antibodies to prevention of biofilm formation in Staphylococcus aureus and Staphylococcus epidermidis strains.
Gholami SA; Goli HR; Haghshenas MR; Mirzaei B
BMC Res Notes; 2019 Oct; 12(1):691. PubMed ID: 31653277
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.
Aguilar-Colomer A; Doadrio JC; Pérez-Jorge C; Manzano M; Vallet-Regí M; Esteban J
J Antibiot (Tokyo); 2017 Mar; 70(3):259-263. PubMed ID: 27999440
[TBL] [Abstract][Full Text] [Related]
34. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
[TBL] [Abstract][Full Text] [Related]
35. Potency and penetration of telavancin in staphylococcal biofilms.
Kirker KR; Fisher ST; James GA
Int J Antimicrob Agents; 2015 Oct; 46(4):451-5. PubMed ID: 26213381
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcus aureus and Staphylococcus epidermidis: emerging pathogens in nosocomial infections.
Ziebuhr W
Contrib Microbiol; 2001; 8():102-7. PubMed ID: 11764727
[No Abstract] [Full Text] [Related]
37. Changes in the composition and architecture of staphylococcal biofilm by nisin.
Andre C; de Jesus Pimentel-Filho N; de Almeida Costa PM; Vanetti MCD
Braz J Microbiol; 2019 Oct; 50(4):1083-1090. PubMed ID: 31456169
[TBL] [Abstract][Full Text] [Related]
38. Effect of different agents with potential antibiofilm activity on antimicrobial susceptibility of biofilms formed by Staphylococcus spp. isolated from implant-related infections.
Molina-Manso D; Del-Prado G; Gómez-Barrena E; Cordero-Ampuero J; Fernandez-Roblas R; Esteban J
J Antibiot (Tokyo); 2016 Sep; 69(9):686-8. PubMed ID: 26905757
[TBL] [Abstract][Full Text] [Related]
39. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
40. Biofilm-formation by Staphylococcus aureus and Staphylococcus epidermidis isolates from subclinical mastitis in conditions mimicking the udder environment.
Seixas R; Varanda D; Bexiga R; Tavares L; Oliveira M
Pol J Vet Sci; 2015; 18(4):787-92. PubMed ID: 26812821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
